Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 14/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10996987 | 0.97 | SLC6A4 (0.50) | SLC6A4SLC6A2SLC6A3MAOAMEN1 | |
| SCHEMBL9473084 | 0.87 | SLC6A4 (0.43) | SLC6A4SLC6A2SLC6A3MAOACYP1A2 | |
| SCHEMBL1575539 | 0.80 | SLC6A4 (0.48) | SLC6A4SLC6A2SLC6A3MAOAMEN1 | |
| SCHEMBL509145 | 0.78 | TRPA1 (0.48) | SLC6A4MEN1KMT2AMAPTTRPA1 | |
| SCHEMBL13026656 | 0.78 | SLC6A4 (0.56) | SLC6A4SLC6A2SLC6A3MAOAMEN1 | |
| SCHEMBL7561792 | 0.78 | TSHR (0.48) | SLC6A4MAOACYP3A4NPC1RAB9A | |
| SCHEMBL81028 | 0.77 | SLC6A4 (0.45) | SLC6A4SLC6A2SLC6A3MAOAMEN1 | |
| SCHEMBL131361 | 0.76 | ALDH1A1 (0.67) | CYP1A2CYP3A4TRPA1ALDH1A1TSHR | |
| SCHEMBL83839 | 0.76 | ALDH1A1 (0.58) | SLC6A4SLC6A2SLC6A3MAOAMEN1 | |
| SCHEMBL257109 | 0.76 | MEN1 (0.55) | SLC6A4SLC6A2SLC6A3MAOAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115959962-B | Visible light-promoted halogenated alkane hydrodehalogenation method | 中国科学院兰州化学物理研究所 | 2025-05-23 | — | — | CN | claimed |
| CN-115850002-B | Method for hydrodehalogenating halogenated alkane | 中国科学院兰州化学物理研究所 | 2025-05-23 | — | — | CN | claimed |
| EP-4626880-A1 | COMPOUNDS FOR MODULATING HUR (ELAVL1) | Shanghai Degron Biomedical Technology Co., Ltd. (CN) | 2025-10-08 | — | — | EP | disclosed |
| CN-115959962-B | Visible light-promoted halogenated alkane hydrodehalogenation method | 中国科学院兰州化学物理研究所 | 2025-05-23 | — | — | CN | disclosed |
| CN-115850002-B | Method for hydrodehalogenating halogenated alkane | 中国科学院兰州化学物理研究所 | 2025-05-23 | — | — | CN | disclosed |
| EP-3604310-B1 | CDC-7-INHIBITOR COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS | CONSEJO SUPERIOR INVESTIGACION (ES) | 2024-09-11 | — | — | EP | disclosed |
| WO-2024114639-A1 | COMPOUNDS FOR MODULATING HUR (ELAVL1) | SHANGHAI DEGRON BIOMEDICAL TECHNOLOGY CO., LTD. (CN) | 2024-06-06 | — | — | WO | disclosed |
| EP-3455224-B1 | SUBSTITUTED 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRIDINE-3(2H)-ONES AND 2,5,6,7-TETRAHYDRO-3H-PYRROLO[2,1-C][1,2,4]TRIAZOL-3-ONES, AND USE THEREOF | BAYER AG (DE) | 2024-03-27 | — | — | EP | disclosed |
| WO-2023242631-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | LEGOCHEM BIOSCIENCES, INC. (KR) | 2023-12-21 | — | — | WO | disclosed |
| CN-115959962-A | Visible light promoted halogenated alkane hydrodehalogenation method | 中国科学院兰州化学物理研究所 | 2023-04-14 | — | — | CN | disclosed |
| CN-115850002-A | Method for hydrodehalogenating halogenated alkane | 中国科学院兰州化学物理研究所 | 2023-03-28 | — | — | CN | disclosed |
| US-5444086-A | Hypoglycemic agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1995-08-22 | — | — | US | disclosed |
| EP-0420941-B1 | PROCESS FOR PRODUCTION OF AROMATIC ALDOXIMES | ALLIED SIGNAL INC (US) | 1994-01-12 | — | — | EP | disclosed |
| EP-0420941-A1 | PROCESS FOR PRODUCTION OF AROMATIC ALDOXIMES. | ALLIED SIGNAL INC (US) | 1991-04-10 | — | — | EP | disclosed |
| WO-1989012623-A1 | PROCESS FOR PRODUCTION OF AROMATIC ALDOXIMES | ALLIED-SIGNAL INC. (US) | 1989-12-28 | — | — | WO | disclosed |
| EP-0032432-B1 | PROSTANOID COMPOUNDS AND THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS | GLAXO GROUP LIMITED (GB) | 1985-07-24 | — | — | EP | disclosed |
| US-4438112-A | PROSTAGLANDINS, ANTICOAGULANTS, ANTIASTHMA | GLAXO GROUP LIMITED (GB) | 1984-03-20 | — | — | US | disclosed |
| US-4342756-A | AS ANTITHROMBOTIC AGENTS AND ANTIASTHMATIC AGENTS | GLAXO GROUP LIMITED (GB) | 1982-08-03 | — | — | US | disclosed |
| EP-0032432-A1 | Prostanoid compounds and their preparation and pharmaceutical formulations | GLAXO GROUP LIMITED (GB) | 1981-07-22 | — | — | EP | disclosed |
| US-3953520-A | Chemical compounds and processes | MERCK & CO., INC. (US) | 1976-04-27 | — | — | US | disclosed |